Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Grünenthal affiliates adopt Veeva CRM solution
Grünenthal Europe & Australia Field Force development head Martine Delage said Veeva CRM’s cloud-based platform has the ability of being able to integrate other systems on a common
Grünenthal Europe & Australia Field Force development head Martine Delage said Veeva CRM’s cloud-based platform has the ability of being able to integrate other systems on a common
Each 400mg vegetarian capsule contains only fresh Red Raspberry Ketones with no added preservatives, fillers and binders, the company said. Ketones are an all-natural phenolic compound that helps
The company has selected Ulverston in Cumbria for the construction of the new biopharmaceutical factory. The £500m investment will also include two manufacturing sites in Scotland at Montrose
Vala will use its Kinetic Image Cytometer platform to demonstrate the suitability and utility of VistaGen’s human pluripotent stem cell derived-cardiomyocytes for screening new drug candidates. VistaGen’s human
The letter also states that bioequivalence was met between the brand product, Temodar, and the company’s generic temozolomide, enabling listing on the Pharmaceutical Benefits Scheme or PBS. Perrigo’s
Particle Sciences, a provider of drug development services, focuses on emulsions, gels, micro and nano-particulates, drug/device combination products and potent compounds across all dosage forms. Particle Sciences CEO
The randomized, double-blind trial enrolled a total of 176 asthma patients in the emergency room not responding to standard pharmacotherapy. The primary efficacy endpoint of the placebo-controlled study
The OSTORA tablets, which will be manufactured in QS Pharma’s Pennsylvania facility, will be used for product launch and commercial sale. This new agreement builds on the continuing
PXVX-0200 is a live attenuated vaccine against cholera, which was previously approved and marketed in six countries under the brand name Orochol. The company expects to begin Phase
Adenosine A2A is a G-protein coupled receptor (GPCR) involved in the regulation of dopaminergic pathways in the brain. As per the agreement Heptares receives upfront option grant and